Encompass Health receives a "buy" rating from SVB Leerink with a $100 price target, as Q1 EPS exceeds estimates by $0.19.
Analyst firm SVB Leerink has given healthcare services company Encompass Health (NYSE:EHC) a "buy" rating and set a $100 price target, suggesting a 16.41% potential upside from the current price. The company's Q1 earnings per share of $1.12 surpassed analysts' estimates by $0.19. Encompass Health has a consensus rating of "Buy" and an average price target of $94.75.
July 12, 2024
4 Articles